
FDA authorizes Abbott's Libre Duo 10 Day, first dual glucose-ketone monitor for diabetes care
Abbott has received FDA authorization for its Libre Duo 10 Day system, the world's first biowearable device that continuously monitors both glucose and ketone levels. This innovation helps people with diabetes detect rising ketones early, which can p...
